Authors:
Edgren, M
Lennernas, B
Haggman, M
Norlen, BJ
Nilsson, S
Citation: M. Edgren et al., Postoperative radiotherapy after prostatectomy can be associated with severe side effects, ANTICANC R, 21(3C), 2001, pp. 2231-2235
Authors:
Edgren, M
Lennernas, B
Larsson, A
Kalkner, KM
Citation: M. Edgren et al., Angiogenic factors: Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma, ANTICANC R, 21(2B), 2001, pp. 1423-1429
Authors:
Ljung, G
Lennernas, B
Nordgren, H
Holmberg, A
Westlin, JE
Nilsson, S
Edgren, M
Citation: G. Ljung et al., Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinomaand immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody, ANTICANC R, 20(4), 2000, pp. 2321-2324
Authors:
Edgren, M
Westlin, JE
Kalkner, KM
Sundin, A
Nilsson, S
Citation: M. Edgren et al., [In-111-DPTA-D-Phe(1)]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma, CANC BIO R, 14(1), 1999, pp. 59-64
Citation: B. Lennernas et al., Patient positioning using artificial intelligence neural networks, trainedmagnetic field sensors and magnetic implants, ACTA ONCOL, 38(8), 1999, pp. 1109-1112
Authors:
Edgren, M
Lennernas, B
Larsson, A
Nilsson, S
Citation: M. Edgren et al., Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinarybladder carcinomas, ANTICANC R, 19(1B), 1999, pp. 869-873